UCAST Ready-made, Ecological Splint Revolutionizes Fracture RX

The New Cast, Consisting of Biodegradable Woodcast Material & Self-adhesive Unitex Fabric, Makes Casting Significantly Faster and Safer.

Today, the materials company Dassiet is launching UCAST – a product line targeted towards hospitals and health centers, making fracture treatment faster and safer both for the patient and nursing staff. Thermoplastic UCAST cast takes only about 5 minutes to apply, while a traditional cast can take up to 30 minutes to prepare. UCAST splints are made of completely non-allergenic and non-toxic materials, and the medical staff does not need to protect themselves for casting. The splint is light-weight, breathable, and unobtrusive to the patient.

Ucast Ready-Made, Ecological Splint

The UCAST splint is made of the wood composite material called Woodcast, which has already been used in hospitals in Finland and around the world for more than 10 years. Woodcast is also used in the field of veterinary medicine, including institutions such as the Veterinary Teaching Hospital in Helsinki. The material is in widespread use in the medical field due to its safety and ease of use. UCAST, developed by casting professionals, will be a big step forward in trauma treatment. It is a breathable and non-toxic cast that removes the need to measure, cut, and clean up during fracture treatment. UCAST also helps hospitals to fight against climate change, as the splint is completely biodegradable, and the fabric can be recycled.

Michael Lindroos, COO at Dassiet, is responsible for the product development and has created UCAST in cooperation with physicians, researchers, and other casters.

“I have carried out the duties of a casting specialist since 1999. Patients’ wellbeing and proper treatment have always been my top priorities, which is why I have spent the past years developing UCAST to make the daily lives of my colleagues and the patient easier. UCAST consists of only two materials: thermoplastic Woodcast splint and padded fabric. Our innovative fabric completely replaces the stockinettes, paddings, bandages and tapes needed during casting. Units using UCAST spend less time on the procedure, which in turn can reduce the waiting time for patients. UCAST is an effective, fast and safe cast, which is something that I always wanted when I was working in a hospital”, Lindroos comments.

In addition to launching UCAST, Dassiet continues product and material development. Recently, the company acquired a leading US company OrthoPets, which produces animal orthoses. Improving veterinary treatment is one of the main focuses of the company. Furthermore, Dassiet offers various industries an opportunity to replace plastic parts with durable and ecological wood composite and biopolymer options.

The first products available in the UCAST product line include a wrist splint and a short thumb splint. Additional products for the treatment of upper and lower limbs will become available soon.

SourceDassiet

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”